Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/08/1998 → 30/06/2003 |
Funding
- Iris Fund For Preventing Blindness: £10,000.00
- Iris Fund For Preventing Blindness: £139,729.00
- Iris Fund For Preventing Blindness: £45,781.00
Prevention of experimental and human uveitis by oral tolerance with heat shock protein derived peptide, linked to cholera toxin B subunit.
- Lehner, Tom (Primary Investigator)
- Stanford, Miles (Primary Investigator)
Project: Research